Maintaining constant blood flow in the face of fluctuations in blood pressure is a critical autoregulatory feature of cerebral arteries. An increase in pressure within the artery lumen causes the vessel to constrict through depolarization and contraction of the encircling smooth muscle cells. This pressure-sensing mechanism involves activation of two types of transient receptor potential (TRP) channels: TRPC6 and TRPM4. We provide evidence that the activation of the g1 isoform of phospholipase C (PLCg1) is critical for pressure sensing in cerebral arteries. Inositol 1,4,5-trisphosphate (IP 3 ), generated by PLCg1 in response to pressure, sensitized IP 3 receptors (IP 3 Rs) to Ca 2+ influx mediated by the mechanosensitive TRPC6 channel, synergistically increasing IP 3 R-mediated Ca 2+ release to activate TRPM4 currents, leading to smooth muscle depolarization and constriction of isolated cerebral arteries. Proximity ligation assays demonstrated colocalization of PLCg1 and TRPC6 with TRPM4, suggesting the presence of a force-sensitive, local signaling network comprising PLCg1, TRPC6, TRPM4, and IP 3 Rs. Src tyrosine kinase activity was necessary for stretch-induced TRPM4 activation and myogenic constriction, consistent with the ability of Src to activate PLCg isoforms. We conclude that contraction of cerebral artery smooth muscle cells requires the integration of pressure-sensing signaling pathways and their convergence on IP 3 Rs, which mediate localized Ca 2+ -dependent depolarization through the activation of TRPM4.
INTRODUCTION
Localized increases in intraluminal pressure provoke vasoconstriction of small arteries and arterioles (1) . This important part of the autoregulatory mechanism, first described by Bayliss and termed the vascular myogenic response (2), allows regional blood flow to remain essentially constant during transient changes in perfusion pressure (3, 4) . Myogenic vasoconstriction results from pressure-induced depolarization of the vascular smooth muscle cell plasma membrane (5) , which causes Ca 2+ influx through voltage-dependent Ca 2+ channels (VDCCs) (6) , as well as increases in the Ca 2+ sensitivity of the contractile apparatus (7) (8) (9) . Longitudinal stretch depolarizes the plasma membrane of isolated arterial myocytes (10) , demonstrating that these cells can directly detect mechanical strain within the vascular wall resulting from pressure increases. However, the underlying molecular mechanisms responsible for sensing stretch and eliciting membrane depolarization remain elusive.
In the simplest theoretical scheme to account for pressure-induced depolarization, stretch of the plasma membrane alters the activity of inherently mechanosensitive ion channels. In support of this possibility, various studies have implicated several members of the transient receptor potential (TRP) cation channel superfamily, including TRPP2 (11), TRPV2 (12), TRPC6 (13) , and TRPM4 (14, 15) , as well as the Ca 2+ -activated Cl − channel TME-M16A (16, 17) , in pressure-induced membrane depolarization. TRPC6 (13) and TRPM4 channels appear to be indispensable for pressure-induced cerebral artery constriction (14, 18) . TRPC6 is a Ca 2+ -permeable, nonselective cation channel that is directly activated by the second messenger diacylglycerol (DAG) (19) . Some studies have reported that TRPC6 channels are inherently mechanosensitive (20) , whereas others have suggested that DAG generated by the activity of phospholipase C (PLC) is involved in mediating the response to stretch (21) . Unlike TRPC6, TRPM4 is impermeant to Ca 2+ , selective for monovalent cations, and activated by increased concentrations of intracellular Ca 2+ (22, 23) . In vascular smooth muscle cells, TRPM4 activity is stimulated by Ca 2+ released from the sarcoplasmic reticulum (SR) through inositol 1,4,5-trisphosphate (IP 3 ) receptors (24, 25) . Despite a report that TRPM4 channels are inherently mechanosensitive based on data obtained from heterologous expression systems (26) , the mechanosensitivity of TRPM4 has not been clearly established.
Although TRPC6 and TRPM4 channels have been implicated in the myogenic response, their position in the pressure-responsive pathway and the mechanism by which their activities are integrated and regulated to achieve a graded response remain unclear. However, the activation of TRPC6 and TRPM4 by DAG and IP 3 , respectively, which are generated by cleavage of the membrane phospholipid phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ] by PLC, suggests that PLC may be centrally involved in stretch-induced activation of both TRPM4 and TRPC6. Because PLC isoforms lack transmembrane domains and thus are unlikely to respond directly to mechanical stimuli, the nature of the stress-sensing entity remains an open question. Several pathways can sense and signal stretch, including actin polymerization (9, 27, 28) and integrin-mediated (29) and G q protein-coupled receptormediated signaling (21) . It is posited that both PLC and TRPC6 play a role in this latter pathway, but details of this signaling cascade remain incompletely characterized and certain key features of the model rely largely on data obtained from heterologous expression systems.
Here, we sought to determine how second messengers generated by PLC and interactions between TRPM4 and TRPC6 channels are linked to bring about pressure-induced membrane depolarization. We showed that generation of IP 3 by the g1 isoform of PLC (PLCg1) was essential for pressure-induced TRPM4 channel activity, smooth muscle membrane depolarization, and generation of myogenic tone. We also showed that PLCg1 activity alone was insufficient to stimulate TRPM4 currents in response to stretch and that Ca 2+ influx through TRPC6 was also required, implying that TRPC6 transduces a mechanical stimulus to TRPM4. Finally, we demonstrated that TRPC6, but not TRPM4, is directly mechanosensitive and that the stress-sensing mechanism upstream of PLCg1 depended on the tyrosine kinase Src. Together, these findings describe a mechanism in which converging signaling pathways integrate the sensation of stretch in vascular smooth muscle cells to mediate pressure-induced membrane depolarization and myogenic vasoconstriction.
RESULTS

TRPM4 is not inherently mechanosensitive
Previous studies have indicated that TRPC6 and TRPM4 are critically involved in pressureinduced cerebral arterial myocyte membrane depolarization (13) (14) (15) 18) , suggesting that these channels can be activated by mechanical stretch. We examined the mechanosensitivity of each channel by measuring changes in single-channel activity in response to membrane stretch induced by applying negative pressure (−20 mmHg) through the recording electrode in patch-clamp experiments using human embryonic kidney (HEK) cells expressing recombinant yellow fluorescent protein (YFP)-tagged TRPC6 or green fluorescent protein (GFP)-tagged TRPM4 (30) . In agreement with previous studies (20, 21) , the total open probability of TRPC6 channels increased nearly threefold in response to stretch of the plasma membrane (Fig. 1A) . Current-voltage relationships recorded under both pressure conditions were linear with a slope conductance consistent with the previously reported unitary conductance of TRPC6 [~35 pS (19) ]. Basal channel activity recorded from HEK cells expressing TRPM4 channels did not change when negative pressure was applied (Fig. 1B) . The slope conductance of these currents was 25 pS, similar to the reported unitary conductance of TRPM4 channels (23) . These data indicate that heterologously expressed TRPC6 channels, but not TRPM4 channels, are mechanosensitive, under the conditions used for this study.
Phospholipase activity is necessary for stretch-induced TRPM4 activity in arterial myocytes
In native, freshly isolated cerebral artery smooth muscle cells, TRPM4 activity can be continuously recorded as transient inward cation currents (TICCs) (25) . TICC activity increased after membrane stretch associated with cell swelling induced by an 80 mosmol/liter hyposmotic challenge (Fig. 1C) . We also examined the mechanosensitivity of TRPM4 in these cells using voltage-clamp in the amphotericin B-perforated configuration, and recorded TICCs when defined amounts of suction were applied to the plasma membrane by the recording electrode. TICC activity increased in proportion to the amount of applied negative pressure ( fig. S1A ). Activation was maximal at an applied intrapipette pressure of −20 mmHg, and the half-maximal pressure of activation (P 50 ) was −12.8 mmHg (fig. S1, A and B) . Stretch-activated increases in TICC activity returned to baseline after release of intrapipette pressure, indicating that current activation did not result from permanent damage to the plasma membrane ( fig. S1 , A and C). Basal and stretch-induced TICC activity was attenuated by the selective TRPM4 inhibitor 9-phenanthrol (15, 31, 32) Fig. 1 . TRPM4 is not intrinsically mechanosensitive, and requires PLC and TRPC6 activity for cell swelling-induced activity. (A) Left: Representative on-cell patch-clamp recording of changes in single-channel activity in a HEK 293 cell transfected with TRPC6-YFP as negative pressure (−20 mmHg) was applied to the patch pipette. Middle: Single-channel current-to-voltage (I/V) amplitude relationship plotted for currents recorded with and without negative pressure (n = 4 to 7 cells in three experiments). Right: Summary of total open probability (NP o ) at the indicated intrapipette pressures at a holding potential of +70 mV (n = 5 cells in three transfection experiments; *P ≤ 0.05). (B) Left: Representative on-cell patch-clamp recording of changes in single-channel activity in a HEK 293 cell transfected with TRPM4-GFP as negative pressure (−20 mmHg) was applied to the patch pipette. Middle: I/V relationship at the indicated intrapipette pressures (n = 4 to 5 cells in three transfection experiments). Right: Summary NP o at the indicated intrapipette pressures at a holding potential of +70 mV (n = 5 cells in three transfection experiments; *P ≤ 0.05). (C) Representative recording and summary of TICC activity after 80 mosmol/liter osmotic challenge (n = 5 cells from three animals; *P ≤ 0.05 compared to control, # P ≤ 0.05 compared to hypotonic). (D) Representative recording and summary of the effects of the PLC inhibitor U73122 on swelling-induced TICC activity (n = 5 cells from three animals; *P ≤ 0.05 compared to control).
( fig. S1D ), demonstrating that currents originated from TRPM4 channels. These findings indicate that TRPM4 is activated by stretch of the plasma membrane in native cerebral artery smooth muscle cells, consistent with the channel's role in myogenic vasoconstriction.
TRPM4 lacks inherent mechanosensitivity, but endogenous TRPM4 channels are activated when stretch is applied to the plasma membrane of arterial myocytes, suggesting that the channel is indirectly activated by force-sensitive signaling pathways in these cells. TRPM4 activity requires high concentrations (~1 to 10 mM) of intracellular Ca 2+ (22, 23) , and in native smooth muscle cells, the channel is stimulated by Ca 2+ released from proximal IP 3 receptors (IP 3 Rs) (24, 25) . IP 3 is generated by PLC-mediated hydrolysis of PtdIns(4,5)P 2 , suggesting that tonic PLC activity is necessary for basal TICC activity. Consistent with this possibility, swelling-induced TICC activity was lost in the presence of U73122 (Fig. 1D) . Furthermore, basal TRPM4 activity was eliminated by the PLC inhibitor U73122 and was restored by the membrane-permeant IP 3 analog Bt-IP 3 ( fig. S1E ). TICC activity was insensitive to U73343, an inactive analog of U73122 ( fig. S2A ). TICC activity stimulated by applying negative pressure to the plasma membrane was also attenuated after administration of U73122 ( fig. S1F ). Control experiments demonstrated that the frequency and amplitude of spontaneous transient outward currents (STOCs), activated by Ca 2+ released from the SR through ryanodine receptors (33), were not altered by U73122 ( fig. S2B ), suggesting that the compound did not alter SR Ca 2+ stores under these conditions. These findings indicate that tonic generation of IP 3 by PLC is necessary for basal and stretch-induced TICC activity in smooth muscle cells.
We assessed the consequences of disrupted stretch-induced, PLC-dependent activation of TRPM4 activity for myogenic constriction using isolated cerebral resistance arteries. In agreement with earlier findings (34) , arteries pretreated with U73122 exhibited diminished pressure-dependent vasoconstriction compared with vessels treated with vehicle controls (fig. S3A ). U73122 pretreatment also decreased vasoconstriction in response to the purinergic receptor vasoconstrictor agonist uridine 5′-triphosphate (UTP) ( fig. S3B ), but constriction in response to increased concentrations of extracellular KCl did not differ between groups ( fig. S3C ). These findings indicate that general PLC activity is necessary for both pressure-and agonist-induced vasoconstriction, and its blockade does not directly influence constriction in response to membrane depolarization.
PLCg1 regulates TRPM4 activity in arterial myocytes
Several PLC isoforms are present in vascular smooth muscle cells (35) . We detected PLCg1, PLCg2, and PLCb2 in native cerebral artery smooth muscle cells using reverse transcription polymerase chain reaction (RT-PCR) and immunocytochemistry (Fig. 2, A and B ). PLCg1 and PLCg2 immunolabeling appeared at or near the plasma membrane, whereas PLCb2 immunolabeling was detected as discrete puncta located primarily within the cytosol (Fig. 2B ). TRPM4 immunolabeling was also concentrated at or near the plasma membrane (Fig. 2B) . We used an in situ proximity ligation assay (36) to identify PLC isoforms that are closely associated with TRPM4 in cerebral myocytes. This technique produces positive immunolabeling only if the two targeted proteins are localized within 40 nm of each other. Dual immunolabeling for PLCg1 and TRPM4 produced significantly higher numbers of puncta per cell near the plasma membrane than were detected with dual labeling for TRPM4 and PLCg2 or PLCb2 (Fig. 2C) . These findings suggest that PLCg1 and TRPM4 are within 40 nm of each other near the plasma membrane in contractile smooth muscle cells, indicating that PLCg1 could be selectively involved in the regulation of TRPM4 activity. Small interfering RNA (siRNA) was used to test the hypothesis that PLCg1 regulates TRPM4 activity in native cerebral artery smooth muscle cells. siRNA targeting PLCg1 or control (scrambled) siRNAwas introduced into the arterial myocytes of intact cerebral arteries using a previously described reversible permeabilization technique (25) (fig. S4 ). TICCs were recorded from arterial myocytes, enzymatically isolated from vessels treated with PLCg1 or control (nonsilencing) siRNA, whereas stretch was applied to the plasma membrane. Cells isolated from PLCg1 siRNA-treated vessels exhibited an about 73% decrease in stretch-induced TICC activity compared with cells from vessels treated with control siRNA (Fig. 2D) . TICC activity in cells isolated from vessels treated with PLCg1 siRNA was partially restored by administration of Bt-IP 3 (Fig. 2D) , indicating that diminished IP 3 production after PLCg1 silencing contributes to the loss of TRPM4 activity. These findings demonstrate that the activity of PLCg1 is necessary for the generation of TRPM4 currents in cerebral myocytes in response to stretch of the plasma membrane.
PLCg1 is essential for pressure-induced smooth muscle cell depolarization and the development of myogenic tone Acute knockdown of TRPM4 largely eliminates pressure-induced smooth muscle cell depolarization and myogenic constriction of cerebral arteries (14, 15) , and the current findings indicate that stretch-induced TRPM4 activity is dependent on the generation of IP 3 by PLCg1. Therefore, we examined the role of PLCg1 in pressure-induced smooth muscle membrane depolarization and vasoconstriction using siRNA-mediated silencing in intact cerebral arteries. Microelectrode recordings obtained from pressurized vessels demonstrated that the mean membrane potential of smooth muscle cells in control siRNA-treated arteries was −59.5 ± 6.6 mV at rest and was depolarized to −39.0 ± 3.0 mV by an increase in pressure to 80 mmHg. This response was significantly attenuated in PLCg1 siRNA-treated arteries, demonstrating a role for PLCg1 in pressure-induced depolarization of cerebral artery smooth muscle cells (Fig. 3, A and B) . Moreover, myogenic tone was essentially abolished in PLCg1 siRNA-treated arteries (Fig. 3 , C and D), demonstrating a requirement for PLCg1 in the myogenic response to pressure. In contrast, we found that agonist-induced vasoconstriction with UTP did not differ between PLCg1 siRNA-and control siRNA-treated vessels ( Fig. 3E ), indicating that PLCg1 activity is not involved in purinergic receptormediated vasoconstriction. Arterial constriction in response to increased extracellular K + ion concentration did not differ between PLCg1 siRNAand control siRNA-treated vessels (Fig. 3F ), indicating that absence of PLCg1 does not directly impair membrane depolarization-dependent vasoconstrictor pathways. These findings show that PLCg1 is specifically involved in pressure-induced smooth muscle cell depolarization and is required for the development of myogenic tone. Considering the inhibitory effects of U73122 on UTP-mediated vasoconstriction (Fig. 2B ), the absence of an effect of PLCg1 on the contractile response to UTP suggests that agonist-induced vasoconstrictor responses require the activity of a different PLC isoform (for example, PLCb). The close proximity of PLCg1 and TRPM4 ( Fig. 2C ) and our previous work showing that TRPM4 and IP 3 receptors are functionally coupled (24) suggest that TRPM4, PLCg1, and IP 3 receptors are part of a force-sensitive signaling network in vascular smooth muscle cells that mediates membrane potential depolarization in response to increases in intraluminal pressure.
Ca
2+ influx through TRPC6 is required for pressure-induced Ca 2+ waves and activation of TRPM4
Previous studies have shown that knocking down either TRPM4 or TRPC6 largely eliminates (~80 to 90%) the myogenic response in cerebral arteries, consistent with a serial mechanism (13, 14) . However, we previously have shown that TRPM4 channels are not responsive to extracellular Ca 2+ influx, arguing against a direct link between TRPC6-mediated Ca 2+ influx and TRPM4 activation in the myogenic response. In particular, TRPM4 is activated by IP 3 R-mediated release of Ca 2+ from intracellular stores. An alternative mechanism that is compatible with these observations and a serial linkage between TRPC6 and TRPM4 is a Ca 2+ -induced Ca 2+ -release mechanism in which Ca 2+ influx through stretch-activated TRPC6 channels activates IP 3 Rs, promoting the release of Ca 2+ from intracellular stores that, in turn, stimulates TRPM4 activity. This mechanism predicts that stretch induces Ca 2+ influx and release from intracellular stores and that both events are required to activate TRPM4. We examined the role of TRPC6-mediated Ca 2+ influx in pressure-induced Ca 2+ waves in arteries and stretch-activated TRPM4 currents in freshly isolated myocytes. In intact pressurized arteries that were continuously exposed to the L-type Ca 2+ channel blocker nimodipine and the ryanodine receptor blocker tetracaine to isolate IP 3 R-mediated events, the percentage of vascular smooth muscle cells exhibiting spontaneous propagating Ca 2+ waves increased in a pressure-dependent manner (Fig. 4A ). Preincubation with a TRPC6 antibody targeting an extracellular epitope eliminated these intraluminal pressure-induced Ca 2+ waves (Fig. 4 , A and B) and blocked currents in TRPC6-expressing HEK 293 cells ( fig. S6 ). In vessels preincubated with the inhibitory antibody, administration of the purinergic receptor agonist UTP restored Ca 2+ waves (Fig. 4 , A and B), possibly through G q protein-coupled receptor-dependent activation of TRPC3 (37) . These results suggest that increases in intraluminal pressure and stretch of the plasma membrane elicit Ca 2+ release through IP 3 Rs and that this response is governed by activation of plasma membrane TRPC6 channels.
To determine whether Ca 2+ influx through TRPC6 was necessary for the pressure-dependent, IP 3 R-mediated activation of TRPM4, we examined the role of TRPC6 in stretch-induced TICC activity. Internal SR Ca 2+ stores were maintained after acute removal of extracellular Ca 2+ , accomplished by immediate (<1 to 2 min) exposure to zero extracellular Ca 2+ ( fig. S5 ). Under these conditions, stimulated Ca 2+ release events from internal stores are maintained (38) . Removal of extracellular Ca 2+ prevented stretch-induced increases in TRPM4 activity (Fig. 4B ). In agreement with our previous findings (24, 25) , depletion of SR Ca 2+ stores with the sarco/endoplasmic reticulum Ca 2+ -adenosine triphosphatase (ATPase) (SERCA) inhibitor cyclopiazonic acid essentially abolished both basal and stretch-induced TICC activity (Fig. 4C ). These data indicate that Ca 2+ influx and intact SR Ca 2+ stores are necessary for stretch-induced increases in TRPM4 activity in native smooth muscle cells.
We next sought to establish that TRPC6, which is Ca 2+ -permeable, activated by plasma membrane stretch (13, 20, 21 ) (see also Fig. 1A) , and necessary for myogenic vasoconstriction of cerebral arteries (13) , is the mechanosensitive ion channel involved in this response. Using in situ proximity ligation assay, we found that TRPC6 channels, but not large-conductance Ca 2+ -activated K + (BK Ca ) channels, are within 40 nm of TRPM4 channels (Fig. 4D) . These data indicate that TRPC6 channels are positioned to provide the Ca 2+ influx necessary for stretch-induced activation of TRPM4. Stretch-induced increases in TRPM4 activity were attenuated by GsMTx-4, a peptide derived from the venom of the Chilean rose hair tarantula that inhibits mechanosensitive ion channels, including TRPC6 (20) (Fig. 4E) . GsMTX-4 blocked recombinant TRPC6 channels expressed in HEK 293 cells, but had no direct effects on heterologously expressed TRPM4 channels ( fig. S6) . These results indicate a functional linkage between TRPC6 and TRPM4. Stretch-activated TRPM4 currents in cerebral artery myocytes were also attenuated by an antibody that binds to an extracellular epitope of TRPC6 (Fig. 4E, middle) , providing additional support for functional communication between TRPC6 and TRPM4. The anti-TRPC6 antibody blocked currents recorded from TRPC6-expressing HEK 293 cells, but not those recorded from HEK 293 cells transfected with TRPM4 ( fig. S6 ), and did not affect currents recorded from cerebral artery myocytes when coadministered with its antigenic peptide (Fig.  4E) , indicating that these effects were specific. Consistent with these observations and the results of in situ proximity ligation assay experiments, the anti-TRPC6 antibody immunolabeled the plasma membrane of native cerebral artery smooth muscle cells but failed to immunolabel these cells when the antibody was preincubated with the antigenic peptide (Fig. 4E, right) . In addition, swelling-induced TICC activity was absent in cells that were preincubated with the TRPC6 inhibitory antibody (Fig. 4F) . Collectively, these data indicate that Ca 2+ influx through TRPC6 is necessary for stretch-induced IP 3 R Ca 2+ -mediated activation of TRPM4 in contractile cerebral artery smooth muscle cells.
AT 1 receptors and Src family tyrosine kinase activity contribute to stretch-induced TRPM4 activity in arterial myocytes
The dependence of the myogenic response on PLCg1 and the presumed absence of PLC mechanosensitivity prompted us to address the possible upstream involvement of the Src family of nonreceptor tyrosine kinases, which can signal through PLCg isoforms (35) and rapidly activate in response to mechanical stress (39) . Consistent with a role for Src family tyrosine kinases in this pathway, we found that two structurally unrelated Src inhibitors, PP2 (Fig. 5A) or SKI-1 ( fig. S7A ), inhibited stretch-induced TRPM4-mediated currents. Administration of the Src kinase inhibitors PP2 (Fig. 5B) and SKI-1 ( fig. S7B ) nearly abolished predeveloped myogenic tone in isolated cerebral arteries. PP2 did not affect KCl-induced constriction (Fig. 5C ). These data indicate that Src tyrosine kinase activity is required for the development of myogenic tone. Previous work indicated that stimulation of angiotensin II (Ang II) receptor type 1 (AT 1 R) initiates Src tyrosine kinase-dependent phosphorylation of PLCg1 in smooth muscle cells (40) . In agreement with these results, administration of the AT 1 R inhibitor losartan prevented stretch-induced increases in TRPM4 activity (Fig. 5D) , suggesting a possible upstream role for this G q/11 -coupled receptor in the pressure-response pathway.
The findings presented here support a signaling pathway (Fig. 6 ) in which pressure induces PLCg1 activity through Src tyrosine kinase, likely with the involvement of the upstream G q/11 -coupled receptor AT 1 R, -release mechanism, resulting in activation of proximal TRPM4 channels in response to increases in luminal pressure. Our previous observation that the TRPM4 inhibitor 9-phenanthrol relaxes vessels with tone independent of a change in pressure (15) suggests that this mechanism also operates under steady-state conditions, although it is possible that other pathways contribute.
PLC activity is necessary for the development of myogenic tone (34, 41, 42) , such that pharmacological inhibition leads to hyperpolarization and disruption of sustained pressure-induced constriction of arteries (34, 41) . Intracellular concentrations of endogenous IP 3 in smooth muscle cells are higher in myocytes isolated from vessels exposed to higher intraluminal pressures (46) , suggesting a positive relationship between PLC activity and membrane stretch. In addition, Mufti et al. reported an increase in IP 3 R-mediated Ca 2+ -release events in cerebral arteries in response to higher intraluminal pressure (47) . These data suggest that pressure can stimulate PLC activity, thereby generating IP 3 and the subsequent release of Ca 2+ through IP 3 Rs. Yet, PLC is a common signaling enzyme with multiple isoforms that contribute to different signaling pathways. PLCg1 is located proximal to TRPM4 and is a key element in stretch-induced, but not agonist-dependent, TRPM4 activation, suggesting that isoform specificity and microdomain localization can prevent crosstalk between different PLC subtypes.
PLCg isoforms are downstream targets of Src tyrosine kinase activity (35) , and previous studies have indicated that PLCg1 can be activated by Src tyrosine kinase-dependent phosphorylation after Ang II-induced AT 1 R stimulation in smooth muscle cells (40) . These studies have advanced the concept that G q protein-coupled receptors, as direct mechanosensors Fig. 6 . Proposed mechanism of stretchdependent activation of TRPM4. Convergence of stretch-sensing pathways in cerebral artery myocytes includes (i) the activation of AT 1 R, Src tyrosine kinase, and PLCg1 in the generation of IP 3 , and (ii) Ca 2+ influx through TRPC6 channels onto IP 3 Rs to activated TRPM4 channels that are responsible for pressure-induced depolarization of the plasma membrane. PM, plasma membrane; DVm, change in membrane potential. (21, 48-50), contribute to myogenic vasoconstriction by activating depolarizing cation currents (21) . Zou et al. demonstrated that agonist-independent, stretch-induced hypertrophy of cardiomyocytes is blocked by inhibition of AT 1 Rs but remains intact in cells isolated from angiotensinogen knockout mice (48) . Furthermore, Mederos y Schnitzler and co-workers have shown that losartan diminishes swelling-induced increases in intracellular Ca 2+ in primary renal arterial smooth muscle cells and partially reverses the myogenic tone of isolated rat cerebral arteries (21) . These authors further reported that all G q protein-coupled receptors tested in an exogenous expression system (HEK cells) confer responsiveness to osmotic swelling when coexpressed with TRPC6, and suggested that mechanosensitivity may be a general feature of G q protein-coupled receptors (21) . Although our data also support a role for AT 1 R in the pressure-dependent activation of TRPC6 (and TRPM4) in cerebral arteries, we found that these effects did not extend to the P2Y receptor, another class of G q protein-coupled receptor. Specifically, whereas general inhibition of PLC eliminated the tone induced by the P2Y receptor agonist UTP ( fig. S3) , knockdown of PLCg1 in vessels did not alter UTP-induced tone (Fig. 3E) . These data suggest that P2Y receptors are not involved in the activation of PLCg1, and thus, activation of this pathway does not appear to be a general property of G q protein-coupled receptors, in contrast to the results reported by Mederos y Schnitzler et al. (21) . One possible explanation is that different PLC isoform(s) could couple to different G q protein-coupled receptors, a question that was not specifically addressed in this previous study. It has been suggested that the purinergic G q protein-coupled receptors P2Y4 or P2Y6, but not AT 1 Rs, are involved in generating myogenic tone in smaller penetrating parenchymal arterioles (51) , implying that different mechanosensitive G q protein-coupled receptors are involved in myogenic tone in different vascular beds. Further investigation is needed to clarify the details of mechanotransduction mechanisms, particularly PLC isoform dependence, and assess the involvement of other PLC-dependent mechanosensitive pathways, such as those involving integrins (52, 53) or other extracellular matrix proteins.
TRPC6 clearly contributes to the generation of myogenic tone (13) , but whether these channels are directly or indirectly mechanosensitive has been a matter of controversy. TRPC6-deficient mice have been reported to exhibit enhanced membrane depolarization, myogenic tone, and increased blood pressure (54), a phenotype that has been attributed to up-regulation of constitutively active, DAG-sensitive TRPC3 channels. In addition, an acute antisense strategy directed against TRPC6 in intact cerebral arteries, which prevents functional compensation by closely related channels, results in attenuation of pressure-dependent depolarization (13) . These data implicate TRPC6 as a player in the pressure-sensing mechanism but do not address whether this channel responds directly or indirectly to mechanical stretch. Various groups have characterized mechanosensitive channels in smooth muscle cells (55) (56) (57) , including Park et al., who have identified stretchactivated cation channels in native vascular smooth muscle cells with a unitary conductance of~30 pS that are stimulated by a DAG analog and require PLC activity (58) , properties that are reminiscent of TRPC channels. These observations are consistent with the possibility that DAG generated by pressureinduced increases in PLCg1 activity stimulate TRPC6 in cerebral artery smooth muscle, but do not preclude direct mechanosensitivity of the channel. In agreement with this possibility, Spassova et al. have reported that stretchinduced activation of recombinant TRPC6 is independent of PLC activity, consistent with the channel exhibiting direct mechanosensitivity (20) .
Collectively, our results define a force-sensitive signaling module in arterial smooth muscle cells in which converging mechanosensitive inputs (namely, AT 1 Rs and TRPC6) are integrated by PLCg1-and IP 3 R-mediated Ca 2+ release to link membrane stretch with membrane depolarization (TRPM4) to generate myogenic tone. Although our model assumes that TRPC6 is directly activated by stretch, it is capable of accommodating an indirect TRPC6 activation mechanism.
MATERIALS AND METHODS
General electrophysiological recordings
Currents were recorded using an Axopatch 200B amplifier equipped with an Axon CV 203BU headstage (Molecular Devices). Recording electrodes (2 to 3 megohms) were pulled, polished, and coated with wax to reduce capacitance. Currents were filtered at 1 kHz, digitized at 40 kHz, and stored for subsequent analysis. Clampex and Clampfit versions 10.2 (Molecular Devices) were used for data acquisition and analysis, respectively. All experiments were performed at room temperature (22°C).
HEK 293 culture and transfection
HEK 293 cells were cultured in 1× high-glucose Dulbecco's modified Eagle's medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (Gibco) and 0.5% penicillin-streptomycin (Gibco). Cells were incubated at 37°C with 6% CO 2 and subcultured when confluent using 0.25% trypsin-EDTA (Gibco), and media were changed every 2 to 3 days. HEK 293 cells were transfected with DNA encoding TRPC6-YFP or TRPM4-GFP using a Gene Pulser Xcell (Bio-Rad, 110-V 25-ms pulse) and transferred to culture flasks. Transfected cells were replated on coverslips 4 hours before patch-clamp experiments.
Electrophysiological recordings from TRPM4-and TRPC6-expressing HEK 293 cells
TRPM4 and TRPC6 single-channel activity was recorded using the cellattached patch-clamp configuration. The patch pipette solution contained 80 mM Cs-aspartate, 30 mM CsCl, 1.5 mM MgCl 2 , 10 mM tetraethylammonium (TEA), 60 mM D-mannitol, and 10 mM Hepes at pH 7.2 (CsOH). Bath solution contained 120 mM KCl, 1.5 mM MgCl 2 , 10 mM Hepes, 50 mM D-mannitol, and 1 mM EGTA at pH 7.4 (KOH). Mechanical stimulation of the cell membrane was accomplished by applying suction (or negative pressure of −20 mmHg) through the recording pipette with a DPM-1B Pneumatic Transducer Tester (Fluke Biomedical).
Conventional whole-cell patch-clamp studies were conducted using nontransfected HEK 293 cells or cells transiently transfected with TRPC6-YFP or TRPM4-GFP. Transfected cells were identified by fluorescence. Cells were pretreated (20 min) with the TRPC6 inhibitor GsMTx-4 (5 mM), a peptide derived from the venom of Grammostola spatulata (Chilean rose hair tarantula), or an anti-TRPC6 inhibitory antibody [1:250, Alomone (ALC-120)]. Macroscopic whole-cell currents from HEK 293 cells transfected with TRPM4-GFP were recorded in external bathing solution containing 146 mM NaCl, 5 mM CaCl 2 , 10 mM Hepes, and 10 mM glucose (pH 7.4). The bathing solution was supplemented with the potassium channel blocker TEA (10 mM). The pipette solution contained 146 mM CsCl, 1 mM MgCl 2 , 10 mM Hepes, and 0.1 mM CaCl 2 . Macroscopic whole-cell currents from HEK 293 cells transfected with TRPC6-YFP were recorded in external bathing solution containing 150 mM NaCl, 0.08 mM KCl, 0.8 mM MgCl 2 , 5.4 mM CaCl 2 , 10 mM Hepes, and 10 mM glucose (pH 7.4). The pipette solution contained 130 mM CsOH, 110 mM aspartic acid, 1 mM MgCl 2 , 10 mM EGTA, and 10 mM Hepes. After baseline currents were recorded, carbachol (10 mM) was administered to induce receptor-mediated TRPC6 currents. For all experiments, cells were initially voltage-clamped at a membrane potential of 0 mV. Currents were measured during voltage ramps between −100 and +100 mV (1.6 s) repeated every 4 s.
Animals
Male Sprague-Dawley rats (250 to 350 g; Harlan) were used for these studies in accordance with protocols approved by the Institutional Animal Care and Use Committees of the Colorado State University. Animals were deeply anesthetized with pentobarbital sodium (50 mg, intraperitoneally) and euthanized by exsanguination. Cerebral and cerebellar arteries were dissected from brains and cleaned of connective tissue in cold Mops-buffered saline composed of 3 mM Mops (pH 7.4), 145 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 2.5 mM CaCl 2 , 1 mM KH 2 PO 4 , 0.02 mM EDTA, 2 mM pyruvate, 5 mM glucose, and 1% bovine serum albumin. Arteries were stored in Mopsbuffered saline on ice before further manipulation.
Cerebral artery smooth muscle cell isolation
Vessels were washed in magnesium-based physiological saline solution (Mg-PSS) containing 5 mM KCl, 140 mM NaCl, 2 mM MgCl 2 , 10 mM Hepes, and 10 mM glucose. Arteries were initially digested in papain (0.6 mg/ml) (Worthington) and dithioerythritol (1 mg/ml) in Mg-PSS at 37°C for 15 min, followed by a 15-min incubation at 37°C in type II collagenase (1.0 mg/ml) (Worthington) in Mg-PSS. The digested arteries were washed three times in ice-cold Mg-PSS solution and incubated on ice for 30 min. After this incubation period, vessels were triturated to liberate smooth muscle cells and stored in ice-cold Mg-PSS before use. Smooth muscle cells were studied within 6 hours after isolation.
Electrophysiological recordings from isolated smooth muscle cells
Isolated smooth muscle cells were placed in a recording chamber (Warner Instruments) and allowed to adhere to glass coverslips for 20 min at room temperature. Gigohm seals were obtained in Mg-PSS. Amphotericin B (40 mM) was included in the pipette solution to perforate the membrane. Perforation was deemed acceptable if series resistance was less than 50 megohms. STOC and TICC activities were recorded in normal external bathing solution containing 134 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM Hepes, and 10 mM glucose at pH 7.4 (NaOH). The pipette solution contained 110 mM K-aspartate, 1 mM MgCl 2 , 30 mM KCl, 10 mM NaCl, 10 mM Hepes, and 5 mM EGTA at pH 7.2 (NaOH). Additional external solutions include Ca 2+ -free external solution containing 134 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 0.73 mM CaCl 2 , 1 mM EGTA, 10 mM Hepes, and 10 mM glucose at pH 7.4 (NaOH). Where specified, a hyperosmotic solution was reached using 100 mM mannitol. A hypotonic challenge of 80 mosmol/liter was achieved by incubating and recording baseline activity in the above hypertonic solution (376 mosmol/liter) followed by exposure to the original recording solution (without mannitol, 296 mosmol/liter). In our recording solutions, the calculated reversal potentials for total monovalent cations were −1.8 and −30.6 mV for monovalent anions (Cl − ). STOCs were defined as transient events greater than 10 pA (more than one BK Ca channel), and the frequency was calculated by dividing the number of events by the time between the first and the last event. Defined amounts of stretch of the plasma membrane were achieved by applying negative pressure through the recording electrode using a DPM-1B Pneumatic Transducer Tester (Fluke Biomedical). Stretch-induced TICC activity was recorded after the administration of 9-phenanthrol (30 mM), U73122 (10 mM), Bt-IP 3 (10 mM), Ang II (100 nM), losartan (1 mM), PP2 (300 nM), GsMTx-4 (5 mM), U73343 (10 mM), or Src family kinase inhibitor-1 (SKI-1, 300 nM). TICC activity at −70 mV was quantified as the calculated sum of the open channel probability of multiple open states of 1.75 pA. This value was based on the reported unitary conductance of TRPM4 (25 pS) . Channel open probability was calculated using the following equation:
where t j is the time spent in seconds, with j = 1, 2, … N channels open; N is the max number of channels observed; and T is the duration of measurement.
Isolated vessel experiments
Arteries were harvested and transferred to a vessel chamber (Living Systems Inc.). The proximal end of the vessel was cannulated with a glass micropipette and secured with monofilament thread. Blood was gently rinsed from the lumen, and the distal end of the vessel was cannulated and secured. Arteries were pressurized to 10 mmHg with PSS composed of 119 mM NaCl, 4.7 mM KCl, 1.8 mM CaCl 2 , 1.2 mM MgSO 4 , 24 mM NaHCO 3 , 0.2 mM KH 2 PO 4 , 10.6 mM glucose, and 1.1 mM EDTA, and superfused (5 ml/min) with warmed (37°C) PSS aerated with a normoxic gas mixture (21% O 2 , 6% CO 2 , balance N 2 ). After a 15-min equilibration period, intraluminal pressure was slowly increased to 80 mmHg, vessels were stretched to remove bends, and pressure was reduced to 20 mmHg for an additional 15-min equilibration period. Inner diameter was continuously monitored using video microscopy and edge detection software (IonOptix). Arteries pressurized to 20 mmHg were exposed to isotonic PSS containing 60 mM KCl to assess viability of the preparation. Arteries were pressurized to 80 mmHg, and stable myogenic tone was allowed to develop before the administration of U73122 (10 mM). To determine maximum (or passive) diameter, vessels were later superfused with Ca 2+ -free PSS: 119 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO 4 , 24 mM NaHCO 3 , 0.2 mM KH 2 PO 4 , 10.6 mM glucose, 1.1 mM EDTA, 3 mM EGTA, and 0.01 mM diltiazem.
Ca
2+ imaging experiments of isolated vessels
Arteries were harvested and incubated in the dark at room temperature in Mops-buffered saline containing 10 mM fluo-4 AM (Invitrogen) and pluronic acid (2.5 mg/ml) for 1.5 hours. Vessels were cannulated on a glass micropipette, pressurized, and superfused with warmed (37°C) modified PSS (125 mM NaCl, 3 mM KCl, 26 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 1 mM MgCl 2 , 4 mM D-glucose, and 2 mM CaCl 2 ,) and aerated with a gas mixture consisting of 20% O 2 , 5% CO 2 , 75% N 2 to maintain pH (pH 7.4). IP 3 Rmediated Ca 2+ waves were isolated by continuously exposing vessels to the L-type Ca 2+ channel blocker nimodipine (300 nM) and the ryanodine receptor blocker tetracaine (100 mM). Images were acquired at 20 frames per second on a 138 × 138-mm field of view (512 × 512 pixels) using a Solamere confocal scanning unit (QLC 100), an electron-multiplying CCD (chargecoupled device) camera, and a 40× water immersion objective. The fluorophore was excited by illumination with a 488-nm krypton/argon laser, and fluorescence emission was collected above 495 nm. Ca 2+ images were acquired using Andor Revolution TL software (Andor Technology) and analyzed with custom software (SparkAn) created by A. D. Bonev (University of Vermont, Burlington, VT).
Reverse transcription polymerase chain reaction
After enzymatic dispersal of rat cerebral arteries, total RNA was extracted (RNeasy Protect Mini Kit, Qiagen Inc.) and first-strand complementary DNA (cDNA) was synthesized using an Omniscript Reverse Transcription Kit (Qiagen Inc.). RT-PCR was performed with the following PLC-specific QuantiTect Primers (Qiagen Inc.) spanning intron/exon boundaries for the following: PLCg1, QT00184100 (Rn_Plcg1_1_SG); PLCg2, QT01080338 (Rn_Plcg2_1_SG); and PLCb2, QT00188062 (Rn_Plcb2_1_SG). PCR products were resolved on 2% agarose gels. These primers yielded PCR products of 84 base pairs (bp) (PLCg1), 108 bp (PLCg2), and 102 bp (PLCb2). All PCRs included a template-free control. RT-PCR experiments were repeated using RNA extracted from at least three different animals.
Membrane staining and Mag-fluo-4 Ca 2+ imaging
Cells were enzymatically dissociated from cerebral vessels as described above, and allowed to adhere to glass slides for 20 min at 4°C. Membrane-specific fluorescent staining was performed with ER-Tracker Red (5 mg/ml) (Invitrogen), and SR Ca 2+ stores were assessed using the low-affinity (K d = 22 mM) Ca 2+ indicator Mag-fluo-4 AM (5 mM, Invitrogen). Cells were incubated in ER-Tracker Red and Mag-fluo-4 AM in the patch-clamp recording solution for 30 min at 37°C. Fluorescent images were obtained using a spinning disk confocal microscope (Andor). ER-Tracker Red and Mag-fluo-4 fluorescence were excited by illumination with 543-and 488-nm line, respectively. All images were acquired at 1024 × 1024 pixels and were analyzed using ImageJ [National Institutes of Health (NIH)].
Immunocytochemistry
Cells were enzymatically dissociated from freshly isolated and siRNAtreated vessels as described above. Cells were allowed to adhere to glass slides for 20 min at 4°C, then were fixed with 4% formaldehyde for 10 min, permeabilized with cold methanol (−80°C), and blocked with 2% bovine serum albumin. Cells were incubated in 2% bovine serum albumin blocking solution containing polyclonal primary antibodies overnight at 4°C. Cells were washed and incubated in appropriate fluorescent secondary antibodies for 2 hours at room temperature. Fluorescent images were obtained using a spinning disk confocal microscope (Andor) and a 100× oil immersion objective. Texas Red and fluorescein isothiocyanate (FITC) were excited by illumination with 543-and 488-nm line, respectively. All images were acquired at 1024 × 1024 pixels and were analyzed using a Volocity imaging software package (version 6.0, PerkinElmer Inc.) and ImageJ version 1.42q (NIH). Total fluorescence was determined using the mean fluorescence of the ROI encompassing the whole cell.
Proximity ligation assay
Colocalization of proteins was studied in freshly isolated cerebral artery myocytes using an in situ proximity ligation assay detection kit (Duolink, Olink Biosciences Inc.). Cells were enzymatically dissociated as described. Glass slides were pretreated with a blocking solution containing 1% bovine serum albumin and 1% fish gelatin in Mg-PSS for 10 min at room temperature. Cells were allowed to adhere to glass slides for 20 min at 4°C and fixed with 4% formaldehyde for 10 min at room temperature and 2 hours at 4°C. After subsequent washes in Mg-PSS, cells were permeabilized with cold methanol (−80°C) and incubated overnight in blocking solution containing paired primary antibodies. After incubation in primary antibodies, cells were washed in blocking solution followed by three 10-min washes in 10 ml of Duolink In Situ Wash Buffer A containing 10 mM tris, 150 mM NaCl, and 0.05% Tween 20 (pH 7.4). Cells were incubated in a humidified chamber at 37°C for 60 min with secondary anti-rabbit PLUS and anti-goat MINUS proximity ligation assay probes and later washed three times for 5 min with 10 ml of Wash Buffer A at room temperature. Cells were incubated in ligation ligase solution for 30 min at 37°C in a humidified chamber and later washed three times for 2 min with 10 ml of Wash Buffer A at room temperature. Last, cells were incubated in amplification polymerase solution for 100 min at 37°C in a humidified chamber and later washed twice for 2 min with 10 ml of Duolink In situ Wash Buffer B containing 200 mM tris and 100 mM NaCl (pH 7.5). Cells were further washed with a 1% Wash Buffer B for 1 min and mounted using Duolink In situ Mounting Medium containing DAPI nuclear stain. Fluorescent images were obtained using a spinning disk confocal microscope (Andor) and a 100× oil immersion objective. Generation of positive signal (bright puncta) occurs only when the two proximity ligation assay probes are in close proximity (<40 nm). Excitation of fluorescent puncta was achieved with a 543-nm laser, and autofluorescence of the cytosol was illuminated using a 488-nm laser. Images were analyzed in the Volocity imaging software package (version 6.0, PerkinElmer Inc.). To demonstrate the specificity of the primary antibodies, we performed proximity ligation assay experiments using two antibodies (goat and rabbit) targeting different epitopes of the same protein. Under these conditions, positive proximity ligation assay puncta were observed as the two primary antibodies were bound in close proximity. The density of positive puncta per cell was determined using an automated object-finding protocol in the Volocity imaging software package.
Antibodies
The following primary antibodies were used: anti-PLCg1 (Santa Cruz, sc-426) for immunocytochemistry and proximity ligation assay experiments; antiPLCg2 (Santa Cruz, sc-31751) for immunocytochemistry and proximity ligation assay experiments; anti-PLCb2 (Santa Cruz, sc-206) for immunocytochemistry and proximity ligation assay experiments; anti-TRPC6 (Alomone, ACC-120) for immunocytochemistry, electrophysiology, and Ca 2+ imaging experiments; anti-TRPC6 (Santa Cruz, sc-19197) for proximity ligation assay experiments; anti-TRPM4 (Abcam, ab63080) for immunocytochemistry and proximity ligation assay experiments; anti-TRPM4 (Santa Cruz, sc-67125) for immunocytochemistry and proximity ligation assay experiments; and anti-BK Ca (Alomone, APC-021) for proximity ligation assay experiments. Secondary antibodies used were the following: sheep anti-rabbit Texas Red (Abcam, ab6793-1), bovine anti-rabbit FITC (Santa Cruz, sc-2365), donkey anti-goat Texas Red (Santa Cruz, sc-2783), and donkey anti-goat FITC (Abcam, ab6881).
RNA interference and reverse permeabilization
siRNAs directed against PLCg1 were used to decrease protein abundance in isolated cerebral arteries. siRNAs purchased from Qiagen [1027280 (AllStars Negative Control) and S101961939 (Rn_Plcg1_1)] were dissolved at a concentration of 20 mM in siRNA suspension buffer. Control or PLCg1 siRNAs were introduced into intact cerebral arteries using a reversible permeabilization procedure. Arteries were permeabilized by first incubating segments for 20 min at 4°C in the following solution: 120 mM KCl, 2 mM MgCl 2 , 10 mM EGTA, 5 mM Na 2 ATP, and 20 mM TES (pH 6.8). Arteries were then placed in a similar solution containing siRNA (40 nM) for 3 hours at 4°C and then transferred to a third siRNA-containing solution with increased MgCl 2 (10 mM) for 30 min at 4°C. Permeabilization was reversed by placing arteries in a Mops-buffered physiological siRNA-containing solution consisting of 140 mM NaCl, 5 mM KCl, 10 mM MgCl 2 , 5 mM glucose, and 2 mM Mops (pH 7.1, 22°C) for 30 min at room temperature. Ca 2+ was gradually increased in the latter solution from nominally Ca 2+ -free to 0.01, 0.1, and 1.8 mM over a 45-min period. After the reversible permeabilization procedures, arteries were cultured for 2 to 3 days in DMEM/F-12 culture medium supplemented with L-glutamine (2 mM) (Gibco) and 0.5% penicillin-streptomycin (Gibco).
Real-time RT-PCR
Arteries treated with control or PLCg1 siRNA were enzymatically dissociated, and RNA was immediately isolated, purified, and synthesized into cDNA as described above. PLCg1 mRNA abundance was measured using a real-time SYBR Green detection assay (Bio-Rad), QuantiTect (Qiagen Inc.) primers for PLCg1 [QT00184100 (Rn_Plcg1_1_SG)], and iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad). Samples were normalized to b-actin [QT00193473 (NM_031144)], and cycling parameters were selected on the basis of the protocol for QuantiTect primer assays (Qiagen Inc.). The decrease in PLCg1 mRNA abundance was calculated according to the Pfaffl method (59).
Smooth muscle cell membrane potential
To measure smooth muscle cell membrane potential, cerebral arteries were isolated and pressurized to either 20 or 80 mmHg, and smooth muscle cells were impaled through the adventitia with glass intracellular microelectrodes (tip resistance 100 to 200 megohm). AWPI Intra 767 amplifier was used to record membrane potential (E m ). Analog output from the amplifier was recorded using IonWizard software (sample frequency 20 Hz). Criteria for acceptance of E m recordings were (i) an abrupt negative deflection of potential as the microelectrode was advanced into a cell, (ii) stable membrane potential for at least 1 min, and (iii) an abrupt change in potential to about 0 mV after the electrode was retracted from the cell.
Calculations and statistics
All data are means ± SE. Values of n refer to the number of arteries for the isolated vessel experiments or the number of cells for immunocytochemistry, proximity ligation assay, and patch-clamp experiments. Unpaired Student's t tests were performed to detect differences in total PLCg1-dependent fluorescence from cells isolated from control compared to PLCg1 siRNA-treated vessels and to demonstrate differences in TRPM4: TRPC6 compared to TRPM4:BK Ca proximity ligation assay labeling. In addition, unpaired Student's t tests were performed to detect differences in TICC total open probability from cells isolated from control compared to PLCg1 siRNA-treated vessels and control compared to PLCg1 siRNAtreated vessels treated with Bt-IP 3 . Paired Student's t tests were performed to determine differences in single-channel and macroscopic TRPC6-YFP currents in response to intrapipette pressure, GsMTx-4, and anti-TRPC6 inhibitory peptide. In addition, paired Student's t tests were performed to determine differences in TICC total open probability in response to Bt-IP3 in cells isolated from PLCg1 siRNA-treated vessels. One-way analysis of variance (ANOVA) was performed to demonstrate differences in proximity ligation assay labeling for TRPM4:PLCg1, TRPM4:PLCg2, and TRPM4: PLCb2, and the percentage of cells with Ca 2+ waves in Ca 2+ imaging experiments in pressurized vessels. One-way repeated-measures ANOVAs were performed to demonstrate differences in TICC total open probability in response to intrapipette pressures and after administration of U73122, Bt-IP 3 , and CPA. Two-way repeated-measures ANOVAs were performed to demonstrate differences between TICC total open probability at different intrapipette pressures and in the presence or absence of 9-phenanthrol or extracellular Ca
2+
; myogenic tone at different intraluminal pressures in the presence or absence of U73122; myogenic tone and membrane potential at different intraluminal pressures from control versus PLCg1 siRNA-treated vessels; and arterial tone at different concentrations of UTP from vessels treated with U73122. Individual groups were compared using a StudentNewman-Keuls post hoc test. P ≤ 0.05 was accepted as statistically significant for all experiments.
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